SPONSOR
Dr Cipto Mangunkusumo General Hospital
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Hepatocellular Carcinoma
Dr Cipto Mangunkusumo General Hospital is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Hepatocellular Carcinoma.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Dr Cipto Mangunkusumo General Hospital
How many clinical trials has Dr Cipto Mangunkusumo General Hospital sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Dr Cipto Mangunkusumo General Hospital, of which 1 are actively recruiting participants. These trials cover conditions including Hepatocellular Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Dr Cipto Mangunkusumo General Hospital research focus on?
Dr Cipto Mangunkusumo General Hospital clinical trials span Hepatocellular Carcinoma. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Dr Cipto Mangunkusumo General Hospital clinical trial?
To participate in a Dr Cipto Mangunkusumo General Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Dr Cipto Mangunkusumo General Hospital trials with current recruitment status updated daily.
Clinical Trials by Dr Cipto Mangunkusumo General Hospital
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology